Silvant Capital Management »

Krystal Biotech shares owned by Silvant Capital Management

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Silvant Capital Management from 13F filings

Historical chart of Silvant Capital Management investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Silvant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Silvant Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $30k 80 371.68

More positions owned by Silvant Capital Management

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Ge Vernova (GEV)
Ge Aerospace Com New (GE)
Meta Platforms Cl A (META)
Royal Caribbean Cruises (RCL)
Visa Com Cl A (V)
Arm Holdings Sponsored Ads (ARM)
Amazon (AMZN)
Teradyne (TER)
Netflix (NFLX)

View all positions for Silvant Capital Management

Top funds holding Krystal Biotech

FMR
BlackRock
venBio Select Advisor
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Soleus Capital Management
Capital World Investors
Vestor Capital Corp
Geode Capital Management
Hood River Capital Management
Redmile Group
William Blair Investment Management
T. Rowe Price Associates
Frazier Life Sciences Management

View all funds holding Krystal Biotech